ZAG Zyklotron

ZAG Zyklotron AG is a specialized German radiopharmaceutical company that focuses on the production of short-lived isotopes and positron emission tomography (PET) tracers. Based on the campus of the Karlsruhe Institute of Technology (KIT), the company operates high-performance cyclotrons and automated synthesis modules to manufacture diagnostic agents like [18F]FDG and [18F]NaF. In July 2021, ZAG was acquired by Curium, a global leader in nuclear medicine, to bolster its European manufacturing footprint and supply chain reliability. The company provides GMP-certified radiopharmaceuticals to clinics, hospitals, and research facilities for the detection and monitoring of cancer and neurological disorders. ZAG also offers contract manufacturing and technical services related to cyclotron operation and radiochemistry.